IBIO iBio Inc

Price (delayed)

$1.53

Market cap

$333.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

$0

Enterprise value

$281.37M

Highlights
iBio's revenue has surged by 128% YoY and by 29% QoQ
iBio's gross profit has surged by 104% YoY and by 12% QoQ
The company's net income has shrunk by 54% YoY and by 13% QoQ
IBIO's gross margin is down by 13% from the previous quarter and by 11% YoY

Key stats

What are the main financial stats of IBIO
Market
Shares outstanding
217.85M
Market cap
$333.31M
Enterprise value
$281.37M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.15
Price to sales (P/S)
109.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
93.79
Earnings
Revenue
$3M
EBIT
-$24.41M
EBITDA
-$22.06M
Free cash flow
-$30.13M
Per share
EPS
$0
Free cash flow per share
-$0.14
Book value per share
$0.49
Revenue per share
$0.01
TBVPS
$0.66
Balance sheet
Total assets
$142.7M
Total liabilities
$37.87M
Debt
$32.68M
Equity
$104.85M
Working capital
$101.14M
Liquidity
Debt to equity
0.31
Current ratio
17.67
Quick ratio
17.19
Net debt/EBITDA
2.35
Margins
EBITDA margin
-735.3%
Gross margin
83.6%
Net margin
-895.4%
Operating margin
-820%
Efficiency
Return on assets
-21.7%
Return on equity
-31.1%
Return on invested capital
-33.1%
Return on capital employed
-17.9%
Return on sales
-813.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IBIO stock price

How has the iBio stock price performed over time
Intraday
-0.65%
1 week
-6.13%
1 month
11.68%
1 year
0.66%
YTD
45.71%
QTD
-0.65%

Financial performance

How have iBio's revenue and profit performed over time
Revenue
$3M
Gross profit
$2.51M
Operating income
-$24.6M
Net income
-$26.86M
Gross margin
83.6%
Net margin
-895.4%
iBio's revenue has surged by 128% YoY and by 29% QoQ
iBio's gross profit has surged by 104% YoY and by 12% QoQ
The operating income has dropped by 63% year-on-year and by 15% since the previous quarter
The company's net income has shrunk by 54% YoY and by 13% QoQ

Growth

What is iBio's growth rate over time

Valuation

What is iBio stock price valuation
P/E
N/A
P/B
3.15
P/S
109.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
93.79
The EPS has soared by 100% from the previous quarter and by 100% YoY
IBIO's price to book (P/B) is 34% lower than its 5-year quarterly average of 4.8
The company's equity fell by 2.3% QoQ
iBio's revenue has surged by 128% YoY and by 29% QoQ
IBIO's price to sales (P/S) is 99% more than its 5-year quarterly average of 55.2 but 2.4% less than its last 4 quarters average of 112.6

Efficiency

How efficient is iBio business performance
iBio's return on equity has surged by 99% YoY and by 20% QoQ
iBio's return on assets has surged by 80% YoY and by 10% QoQ
The ROS has grown by 29% YoY and by 11% from the previous quarter
The ROIC has contracted by 22% YoY and by 4.4% from the previous quarter

Dividends

What is IBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IBIO.

Financial health

How did iBio financials performed over time
IBIO's current ratio is down by 2.8% since the previous quarter
IBIO's quick ratio is down by 2.8% from the previous quarter
IBIO's debt is 69% less than its equity
The company's debt to equity has shrunk by 96% YoY
IBIO's debt is down by 2.7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.